2026-07-22 · SOL/USD peg 0.0125● LIVE  Live from the machine markets
INFLUEX
On-chain memecoin trading — directory & desk
Analytics · Multi-chain

DexScreener

The de facto standard for real-time DEX charts and new-pair discovery -- free, fast and multi-chain, with only paid Boosts to watch for.

Multi-chainFree; paid Boost promotion for projectsEst. 2021By The Influex deskJuly 2026

Pros

  • Free with no registration
  • Covers 100+ chains and thousands of DEXs
  • Fastest new-pair discovery in the space
  • Pro charting: multi-chart, RSI, MACD, alerts

Cons

  • Paid Boost promotions can flatter tokens
  • Analytics only, no trade execution
  • Data can't vouch for a token's legitimacy

DexScreener is the tool almost every on-chain trader opens first: a free, real-time analytics and charting platform for decentralized exchanges across dozens of blockchains.

What it is

Founded in 2021, DexScreener aggregates on-chain data from more than 100 networks and thousands of DEXs, letting users monitor token prices, liquidity, volume, and transaction activity. Unlike tools built around centralized exchanges, it specializes in decentralized markets and has become the default discovery engine for assets not yet listed anywhere else.

How it works

Each pair page shows liquidity, 24h volume, transaction counts, buy vs. sell pressure, and market-cap estimates. Its charting is professional-grade -- MultiCharts for up to 16 TradingView panels at once, plus indicators like RSI, moving averages, MACD, and Bollinger Bands. Its indexer is known for detecting newly created pairs within seconds, typically beating competitors, which is why it's the go-to for early discovery. It's free with no registration; revenue comes from a clearly labelled "Boost" feature that lets projects pay to promote tokens.

The verdict

DexScreener is close to essential and, unlike the trading tools here, it doesn't put your funds at risk -- it's read-only. The one thing to keep in mind is that paid Boosts and slick charts can make a token look more alive than it is; the data describes a market, it doesn't validate a project. Use it as your dashboard, do the diligence elsewhere, and it's hard to fault.

Official site: DexScreener — dexscreener.com

analyticschartsdiscovery
← Back to the directory